pyrrolidonecarboxylic acid has been researched along with indican in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, D; Boerwinkle, E; Coresh, J; Nettleton, JA; Yu, B; Zheng, Y | 1 |
| Arakawa, S; Bamba, T; Fukusaki, E; Furuno, M; Katakami, N; Matsuoka, TA; Omori, K; Shimomura, I; Takahara, M; Taya, N; Tsugawa, H | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and indican
| Article | Year |
|---|---|
Serum metabolomic profiling and incident CKD among African Americans.
Topics: Biomarkers; Black or African American; Chromatography, Liquid; Creatine; Cross-Sectional Studies; Deoxyglucose; Female; Gas Chromatography-Mass Spectrometry; Humans; Incidence; Indican; Kidney; Linear Models; Longitudinal Studies; Male; Metabolomics; Middle Aged; Proportional Hazards Models; Pyrrolidonecarboxylic Acid; Renal Insufficiency, Chronic; Risk Factors; Time Factors; United States | 2014 |
Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes.
Topics: Aged; Ankle Brachial Index; Biomarkers; Diabetes Mellitus, Type 2; Erythritol; Female; Gas Chromatography-Mass Spectrometry; Humans; Indican; Male; Mannitol; Metabolomics; Middle Aged; Peripheral Arterial Disease; Pyrrolidonecarboxylic Acid; Vascular Stiffness | 2020 |